世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

世界および日本の白斑治療薬の市場規模、現状、予測2021-2027年


Global and Japan Vitiligo Therapeutics Market Size, Status and Forecast 2021-2027

白斑は、長期にわたる皮膚疾患で、皮膚の一部が色素を失うことが特徴です。罹患した皮膚のパッチは白色になり、通常は鋭い縁取りがあります。また、髪の毛も白くなることがあります。 市場分析と洞察。白斑治... もっと見る

 

 

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ
2021年11月5日 US$3,900
シングルユーザライセンス
ライセンス・価格情報・注文方法はこちら
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

白斑は、長期にわたる皮膚疾患で、皮膚の一部が色素を失うことが特徴です。罹患した皮膚のパッチは白色になり、通常は鋭い縁取りがあります。また、髪の毛も白くなることがあります。

市場分析と洞察。白斑治療薬の世界市場
白斑治療薬の世界市場規模は、2020年のXX百万米ドルから、2021-2027年の間にXX%のCAGRで、2027年にXX百万米ドルに達すると予測されます。
本レポートは、業界標準の正確な分析と高いデータの整合性により、世界の白斑治療薬市場で得られる主要な機会を明らかにし、プレイヤーが市場での確固たる地位を獲得するのに役立つ見事な試みを行っています。本レポートの購入者は、白斑治療薬の世界市場全体の規模(売上高)など、検証済みの信頼できる市場予測にアクセスすることができます。
全体として、本レポートは、プレイヤーが競合他社に対する競争力を獲得し、世界の白斑治療薬市場で永続的な成功を収めるために利用できる効果的なツールであることを証明しています。本レポートに掲載されている調査結果、データ、情報はすべて、信頼できる情報源の助けを借りて検証、再検証されています。本レポートを執筆したアナリストは、世界のVitiligo Therapeutics市場を詳細に調査するために、ユニークで業界最高の調査・分析アプローチを採用しました。

世界の白斑治療薬の範囲と市場規模
白斑治療薬市場は、企業別、地域(国)別、タイプ別、アプリケーション別に分類されます。世界のVitiligo Therapeutics市場に参加するプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして活用することで、優位に立つことができるでしょう。セグメント別分析では、2016年から2027年までの期間における、タイプ別、アプリケーション別の収益と予測に焦点を当てています。

タイプ別セグメント
局所用
経口用
その他

用途別セグメント
病院薬局
小売薬局
オンライン薬局

地域別
北アメリカ
U.S.
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
北欧
その他のヨーロッパ諸国
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
その他のアジア諸国
ラテンアメリカ
メキシコ
ブラジル
その他のラテンアメリカ
中近東・アフリカ
トルコ
サウジアラビア
アラブ首長国連邦
その他の中東・アフリカ地域

会社別
バウシュ・ヘルス
バクスター
ブリストル・マイヤーズ スクイブ(Bristol-Myers Squibb
セルジーン
アステラス製薬
Aclaris Therapeutics
プニート・ラボラトリーズ
クリヌベル・ファーマシューティカルズ


ページTOPに戻る


目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Vitiligo Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Topical
1.2.3 Oral
1.2.4 Others
1.3 Market by Application
1.3.1 Global Vitiligo Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Vitiligo Therapeutics Market Perspective (2016-2027)
2.2 Vitiligo Therapeutics Growth Trends by Regions
2.2.1 Vitiligo Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Vitiligo Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Vitiligo Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Vitiligo Therapeutics Industry Dynamic
2.3.1 Vitiligo Therapeutics Market Trends
2.3.2 Vitiligo Therapeutics Market Drivers
2.3.3 Vitiligo Therapeutics Market Challenges
2.3.4 Vitiligo Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Vitiligo Therapeutics Players by Revenue
3.1.1 Global Top Vitiligo Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Vitiligo Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Vitiligo Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Vitiligo Therapeutics Revenue
3.4 Global Vitiligo Therapeutics Market Concentration Ratio
3.4.1 Global Vitiligo Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Vitiligo Therapeutics Revenue in 2020
3.5 Vitiligo Therapeutics Key Players Head office and Area Served
3.6 Key Players Vitiligo Therapeutics Product Solution and Service
3.7 Date of Enter into Vitiligo Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Vitiligo Therapeutics Breakdown Data by Type
4.1 Global Vitiligo Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Vitiligo Therapeutics Forecasted Market Size by Type (2022-2027)

5 Vitiligo Therapeutics Breakdown Data by Application
5.1 Global Vitiligo Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Vitiligo Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Vitiligo Therapeutics Market Size (2016-2027)
6.2 North America Vitiligo Therapeutics Market Size by Type
6.2.1 North America Vitiligo Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Vitiligo Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Vitiligo Therapeutics Market Size by Type (2016-2027)
6.3 North America Vitiligo Therapeutics Market Size by Application
6.3.1 North America Vitiligo Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Vitiligo Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Vitiligo Therapeutics Market Size by Application (2016-2027)
6.4 North America Vitiligo Therapeutics Market Size by Country
6.4.1 North America Vitiligo Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Vitiligo Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Vitiligo Therapeutics Market Size (2016-2027)
7.2 Europe Vitiligo Therapeutics Market Size by Type
7.2.1 Europe Vitiligo Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Vitiligo Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Vitiligo Therapeutics Market Size by Type (2016-2027)
7.3 Europe Vitiligo Therapeutics Market Size by Application
7.3.1 Europe Vitiligo Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Vitiligo Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Vitiligo Therapeutics Market Size by Application (2016-2027)
7.4 Europe Vitiligo Therapeutics Market Size by Country
7.4.1 Europe Vitiligo Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Vitiligo Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Vitiligo Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Vitiligo Therapeutics Market Size by Type
8.2.1 Asia-Pacific Vitiligo Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Vitiligo Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Vitiligo Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Vitiligo Therapeutics Market Size by Application
8.3.1 Asia-Pacific Vitiligo Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Vitiligo Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Vitiligo Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Vitiligo Therapeutics Market Size by Region
8.4.1 Asia-Pacific Vitiligo Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Vitiligo Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Vitiligo Therapeutics Market Size (2016-2027)
9.2 Latin America Vitiligo Therapeutics Market Size by Type
9.2.1 Latin America Vitiligo Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Vitiligo Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Vitiligo Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Vitiligo Therapeutics Market Size by Application
9.3.1 Latin America Vitiligo Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Vitiligo Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Vitiligo Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Vitiligo Therapeutics Market Size by Country
9.4.1 Latin America Vitiligo Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Vitiligo Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Vitiligo Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Vitiligo Therapeutics Market Size by Type
10.2.1 Middle East & Africa Vitiligo Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Vitiligo Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Vitiligo Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Vitiligo Therapeutics Market Size by Application
10.3.1 Middle East & Africa Vitiligo Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Vitiligo Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Vitiligo Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Vitiligo Therapeutics Market Size by Country
10.4.1 Middle East & Africa Vitiligo Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Vitiligo Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Bausch Health
11.1.1 Bausch Health Company Details
11.1.2 Bausch Health Business Overview
11.1.3 Bausch Health Vitiligo Therapeutics Introduction
11.1.4 Bausch Health Revenue in Vitiligo Therapeutics Business (2016-2021)
11.1.5 Bausch Health Recent Development
11.2 Baxter
11.2.1 Baxter Company Details
11.2.2 Baxter Business Overview
11.2.3 Baxter Vitiligo Therapeutics Introduction
11.2.4 Baxter Revenue in Vitiligo Therapeutics Business (2016-2021)
11.2.5 Baxter Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Details
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb Vitiligo Therapeutics Introduction
11.3.4 Bristol-Myers Squibb Revenue in Vitiligo Therapeutics Business (2016-2021)
11.3.5 Bristol-Myers Squibb Recent Development
11.4 Celgene
11.4.1 Celgene Company Details
11.4.2 Celgene Business Overview
11.4.3 Celgene Vitiligo Therapeutics Introduction
11.4.4 Celgene Revenue in Vitiligo Therapeutics Business (2016-2021)
11.4.5 Celgene Recent Development
11.5 Astellas Pharma
11.5.1 Astellas Pharma Company Details
11.5.2 Astellas Pharma Business Overview
11.5.3 Astellas Pharma Vitiligo Therapeutics Introduction
11.5.4 Astellas Pharma Revenue in Vitiligo Therapeutics Business (2016-2021)
11.5.5 Astellas Pharma Recent Development
11.6 Aclaris Therapeutics
11.6.1 Aclaris Therapeutics Company Details
11.6.2 Aclaris Therapeutics Business Overview
11.6.3 Aclaris Therapeutics Vitiligo Therapeutics Introduction
11.6.4 Aclaris Therapeutics Revenue in Vitiligo Therapeutics Business (2016-2021)
11.6.5 Aclaris Therapeutics Recent Development
11.7 Puneet Laboratories
11.7.1 Puneet Laboratories Company Details
11.7.2 Puneet Laboratories Business Overview
11.7.3 Puneet Laboratories Vitiligo Therapeutics Introduction
11.7.4 Puneet Laboratories Revenue in Vitiligo Therapeutics Business (2016-2021)
11.7.5 Puneet Laboratories Recent Development
11.8 Clinuvel Pharmaceuticals
11.8.1 Clinuvel Pharmaceuticals Company Details
11.8.2 Clinuvel Pharmaceuticals Business Overview
11.8.3 Clinuvel Pharmaceuticals Vitiligo Therapeutics Introduction
11.8.4 Clinuvel Pharmaceuticals Revenue in Vitiligo Therapeutics Business (2016-2021)
11.8.5 Clinuvel Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

 

ページTOPに戻る


 

Summary

Vitiligo is a long-term skin condition characterized by patches of the skin losing their pigment. The patches of skin affected become white and usually have sharp margins. The hair from the skin may also become white.

Market Analysis and Insights: Global Vitiligo Therapeutics Market
The global Vitiligo Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Vitiligo Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Vitiligo Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Vitiligo Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Vitiligo Therapeutics market.

Global Vitiligo Therapeutics Scope and Market Size
Vitiligo Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Vitiligo Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Topical
Oral
Others

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Bausch Health
Baxter
Bristol-Myers Squibb
Celgene
Astellas Pharma
Aclaris Therapeutics
Puneet Laboratories
Clinuvel Pharmaceuticals



ページTOPに戻る


Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Vitiligo Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Topical
1.2.3 Oral
1.2.4 Others
1.3 Market by Application
1.3.1 Global Vitiligo Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Vitiligo Therapeutics Market Perspective (2016-2027)
2.2 Vitiligo Therapeutics Growth Trends by Regions
2.2.1 Vitiligo Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Vitiligo Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Vitiligo Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Vitiligo Therapeutics Industry Dynamic
2.3.1 Vitiligo Therapeutics Market Trends
2.3.2 Vitiligo Therapeutics Market Drivers
2.3.3 Vitiligo Therapeutics Market Challenges
2.3.4 Vitiligo Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Vitiligo Therapeutics Players by Revenue
3.1.1 Global Top Vitiligo Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Vitiligo Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Vitiligo Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Vitiligo Therapeutics Revenue
3.4 Global Vitiligo Therapeutics Market Concentration Ratio
3.4.1 Global Vitiligo Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Vitiligo Therapeutics Revenue in 2020
3.5 Vitiligo Therapeutics Key Players Head office and Area Served
3.6 Key Players Vitiligo Therapeutics Product Solution and Service
3.7 Date of Enter into Vitiligo Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Vitiligo Therapeutics Breakdown Data by Type
4.1 Global Vitiligo Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Vitiligo Therapeutics Forecasted Market Size by Type (2022-2027)

5 Vitiligo Therapeutics Breakdown Data by Application
5.1 Global Vitiligo Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Vitiligo Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Vitiligo Therapeutics Market Size (2016-2027)
6.2 North America Vitiligo Therapeutics Market Size by Type
6.2.1 North America Vitiligo Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Vitiligo Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Vitiligo Therapeutics Market Size by Type (2016-2027)
6.3 North America Vitiligo Therapeutics Market Size by Application
6.3.1 North America Vitiligo Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Vitiligo Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Vitiligo Therapeutics Market Size by Application (2016-2027)
6.4 North America Vitiligo Therapeutics Market Size by Country
6.4.1 North America Vitiligo Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Vitiligo Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Vitiligo Therapeutics Market Size (2016-2027)
7.2 Europe Vitiligo Therapeutics Market Size by Type
7.2.1 Europe Vitiligo Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Vitiligo Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Vitiligo Therapeutics Market Size by Type (2016-2027)
7.3 Europe Vitiligo Therapeutics Market Size by Application
7.3.1 Europe Vitiligo Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Vitiligo Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Vitiligo Therapeutics Market Size by Application (2016-2027)
7.4 Europe Vitiligo Therapeutics Market Size by Country
7.4.1 Europe Vitiligo Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Vitiligo Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Vitiligo Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Vitiligo Therapeutics Market Size by Type
8.2.1 Asia-Pacific Vitiligo Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Vitiligo Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Vitiligo Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Vitiligo Therapeutics Market Size by Application
8.3.1 Asia-Pacific Vitiligo Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Vitiligo Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Vitiligo Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Vitiligo Therapeutics Market Size by Region
8.4.1 Asia-Pacific Vitiligo Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Vitiligo Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Vitiligo Therapeutics Market Size (2016-2027)
9.2 Latin America Vitiligo Therapeutics Market Size by Type
9.2.1 Latin America Vitiligo Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Vitiligo Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Vitiligo Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Vitiligo Therapeutics Market Size by Application
9.3.1 Latin America Vitiligo Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Vitiligo Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Vitiligo Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Vitiligo Therapeutics Market Size by Country
9.4.1 Latin America Vitiligo Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Vitiligo Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Vitiligo Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Vitiligo Therapeutics Market Size by Type
10.2.1 Middle East & Africa Vitiligo Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Vitiligo Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Vitiligo Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Vitiligo Therapeutics Market Size by Application
10.3.1 Middle East & Africa Vitiligo Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Vitiligo Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Vitiligo Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Vitiligo Therapeutics Market Size by Country
10.4.1 Middle East & Africa Vitiligo Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Vitiligo Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Bausch Health
11.1.1 Bausch Health Company Details
11.1.2 Bausch Health Business Overview
11.1.3 Bausch Health Vitiligo Therapeutics Introduction
11.1.4 Bausch Health Revenue in Vitiligo Therapeutics Business (2016-2021)
11.1.5 Bausch Health Recent Development
11.2 Baxter
11.2.1 Baxter Company Details
11.2.2 Baxter Business Overview
11.2.3 Baxter Vitiligo Therapeutics Introduction
11.2.4 Baxter Revenue in Vitiligo Therapeutics Business (2016-2021)
11.2.5 Baxter Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Details
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb Vitiligo Therapeutics Introduction
11.3.4 Bristol-Myers Squibb Revenue in Vitiligo Therapeutics Business (2016-2021)
11.3.5 Bristol-Myers Squibb Recent Development
11.4 Celgene
11.4.1 Celgene Company Details
11.4.2 Celgene Business Overview
11.4.3 Celgene Vitiligo Therapeutics Introduction
11.4.4 Celgene Revenue in Vitiligo Therapeutics Business (2016-2021)
11.4.5 Celgene Recent Development
11.5 Astellas Pharma
11.5.1 Astellas Pharma Company Details
11.5.2 Astellas Pharma Business Overview
11.5.3 Astellas Pharma Vitiligo Therapeutics Introduction
11.5.4 Astellas Pharma Revenue in Vitiligo Therapeutics Business (2016-2021)
11.5.5 Astellas Pharma Recent Development
11.6 Aclaris Therapeutics
11.6.1 Aclaris Therapeutics Company Details
11.6.2 Aclaris Therapeutics Business Overview
11.6.3 Aclaris Therapeutics Vitiligo Therapeutics Introduction
11.6.4 Aclaris Therapeutics Revenue in Vitiligo Therapeutics Business (2016-2021)
11.6.5 Aclaris Therapeutics Recent Development
11.7 Puneet Laboratories
11.7.1 Puneet Laboratories Company Details
11.7.2 Puneet Laboratories Business Overview
11.7.3 Puneet Laboratories Vitiligo Therapeutics Introduction
11.7.4 Puneet Laboratories Revenue in Vitiligo Therapeutics Business (2016-2021)
11.7.5 Puneet Laboratories Recent Development
11.8 Clinuvel Pharmaceuticals
11.8.1 Clinuvel Pharmaceuticals Company Details
11.8.2 Clinuvel Pharmaceuticals Business Overview
11.8.3 Clinuvel Pharmaceuticals Vitiligo Therapeutics Introduction
11.8.4 Clinuvel Pharmaceuticals Revenue in Vitiligo Therapeutics Business (2016-2021)
11.8.5 Clinuvel Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(その他)の最新刊レポート


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/09/20 10:26

143.76 円

160.81 円

193.57 円

ページTOPに戻る